soyasaponin Bb

has activity against polycystic kidney disease; isolated from soybean; structure in first source

Also Known As:

3-O-(rhamnosyl-(1-2)-beta-galactosyl-(1-2)-glucuronosylolean-12-en-3beta,22beta,24-triol

Networked: 5 relevant articles (0 outcomes, 0 trials/studies)

1.	Disease Resistance 01/01/2023 - "Furthermore, the molecular docking indicated that the upregulated metabolites, such as soyasaponin Bb, improve the disease resistance due to highly stable binding with tyrosyl-tRNA synthetase targets in Ralstonia solanacearum and Alternaria alternata. " 01/01/2023 - "CAFFEOYL-COA 3-O-METHYLTRANSFERASE 6/6L can regulate the S/G ratio of lignin monomers and may affect tobacco bacterial wilt and brown spot disease resistance by disturbing phenylpropane and terpene metabolism in leaves and roots of Nicotiana tabacum, such as soyasaponin Bb."
2.	Disease Progression 04/01/2003 - "Evidence that soyasaponin Bb retards disease progression in a murine model of polycystic kidney disease."
3.	Osteoporosis 05/01/2019 - "Thus, PSWE and soyasaponin Bb have the potential to protect against bone disorders, including osteoporosis."
4.	Polycystic Kidney Diseases (Polycystic Kidney Disease) 04/01/2003 - "Evidence that soyasaponin Bb retards disease progression in a murine model of polycystic kidney disease."
5.	Inflammation (Inflammations) 01/01/2016 - "We and others recently showed that soyasaponin Bb (SSBb ) inhibited lipopolysaccharide (LPS)-induced inflammation in macrophages. "